ANA MONTOYA MATUTE-rekin lankidetzan egindako argitalpenak (73)

2024

  1. Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis

    Frontiers in Veterinary Science, Vol. 11

  2. Corrigendum: Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis (Frontiers in Veterinary Science, (2024), 11, (1368929), 10.3389/fvets.2024.1368929)

    Frontiers in Veterinary Science

  3. Cystoisospora spp. infection at a dog breeding facility in the Madrid region: Infection rate and clinical management based on toltrazuril metaphylaxis

    Veterinary Parasitology: Regional Studies and Reports, Vol. 48

  4. Enhancing diagnostic accuracy: Direct immunofluorescence assay as the gold standard for detecting Giardia duodenalis and Cryptosporidium spp. in canine and feline fecal samples

    BMC veterinary research, Vol. 20, Núm. 1, pp. 445

  5. Feline leishmaniosis in the Mediterranean Basin: a multicenter study

    Parasites and Vectors, Vol. 17, Núm. 1

  6. High serological and molecular prevalence of Ehrlichia canis and other vector-borne pathogens in dogs from Boa Vista Island, Cape Verde

    Parasites and Vectors , Vol. 17, Núm. 1

  7. Performance of a point-of-care test for the detection of anti-Leishmania infantum antibodies is associated with immunofluorescent antibody titer and clinical stage of leishmaniosis in dogs from endemic regions

    Veterinary Parasitology: Regional Studies and Reports, Vol. 53

  8. Relapses in canine leishmaniosis: risk factors identified through mixed-effects logistic regression

    Parasites and Vectors, Vol. 17, Núm. 1